IP Library Assignment 048504/0479
Patent Assignment
Reel/Frame 048504/0479

Change of Name

Recorded: 2019-03-05 Pages: 3
Assignor
NEURON SYSTEMS, INC.
Executed: 2012-12-20
Assignee
ALDEXA THERAPEUTICS, INC.
15 NEW ENGLAND EXECUTIVE PARK, BURLINGTON, MASSACHUSETTS, 01803
Covered Property (1)
Compositions and Methods of Treating Retinal Disease
Application: 16/241,851 →
Publication: US 2019/0210971
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 5, 2019
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 048504/0074 →
Change of Address Mar 5, 2019
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 048504/0365 →
Change of Name Mar 5, 2019
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 048504/0666 →
Assignment of Assignor's Interest Feb 10, 2021
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 055208/0421 →